Bionpharma FDA Monday, April 14, 2025 0.00 Neutral

FDA Approves METFORMIN HYDROCHLORIDE ORAL SOLUTION — Bionpharma Inc.,

BIONPHARMA INC. announced the U.S. approval of generic metformin hydrochloride oral solution (ANDA 219151), a move that is expected to bolster supply chain stability for the widely prescribed diabetes management medication. This approval will ultimately expand market competition, potentially exerting downward pressure on pricing for the essential oral drug.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed